MAP1 Antibody (4A1)

This product is produced by and distributed for Abnova, a company based in Taiwan.

A protein termed MAP1 has recently been identified. This protein contains a BH3-like domain and induces caspase-dependent apoptosis in mammalian cells when overexpressed. It forms homodimers and associates with Bcl-2 family members such as Bax, Bcl-2, and Bcl-XL in vitro and in vivo. It has been suggested that MAP1 associates with the tumor suppressor RASSF1A following death receptor activation, allowing a conformational change in Bax that leads to cellular apoptosis.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 1 application: WB.

Showing Publication 1 - 1 of 1.

Publication using H00064112-M02	Applications	Species
Pandeya A, Khalko R, Mishra A et al. Human Cytomegalovirus miR-UL70-3p Downregulates the H2O2-Induced Apoptosis by Targeting the Modulator of Apoptosis-1 (MOAP1) International Journal of Molecular Sciences 2021-12-21 [PMID: 35008453] (WB, Human)	WB	Human

Array H00064112-M02

• MAP1 Antibodies
• MAP1 Lysate
• MAP1 Proteins